Advisor Group, Inc. - IMMUNE PHARMACEUTICALS INC ownership

IMMUNE PHARMACEUTICALS INC's ticker is IMNPQ and the CUSIP is 45254C200. A total of 13 filers reported holding IMMUNE PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of IMMUNE PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2018$1,000
-50.0%
3,7500.0%0.00%
Q4 2017$2,000
-66.7%
3,7500.0%0.00%
Q3 2017$6,000
-50.0%
3,7500.0%0.00%
Q2 2017$12,0003,7500.00%
Other shareholders
IMMUNE PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TWO SIGMA SECURITIES, LLC 26,975$41,0000.00%
VANGUARD GROUP INC 226,437$342,0000.00%
UBS Group AG 6,562$10,0000.00%
IFP Advisors, Inc 1$00.00%
Advisor Group, Inc. 3,750$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 22,355$33,0000.00%
DEUTSCHE BANK AG\ 4$00.00%
MORGAN STANLEY 5$00.00%
BlackRock Inc. 568$1,0000.00%
Steward Partners Investment Advisory, LLC 250$00.00%
View complete list of IMMUNE PHARMACEUTICALS INC shareholders